Mirna Mina-Abouda

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 17, 2026
Metallothionein loss in cancer cells contributes to increased mutations through defective DNA repair and metabolic imbalance.

|Jan 25, 2025
Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer.

Amy Rees, Evan Villamor, Della Evans

Pageof 1

Frequent Collaborators

2 joint publications

Joe R Delaney

1 joint publications

Monika Gooz